PENSIONERS POST - Increase the Subscriptions!
17 hours ago
Thursday, December 31, 2020
TRAVELLING ALLOWANCE RULES-
PRODUCTION OF RECEIPTS/VOUCHERS FOR REIMBURSEMENT OF TRAVELLING CHARGES FOR
TRAVEL WITHIN THE CITY ADMISSIBLE UNDER DAILY ALLOWANCE ON TOUR CLICK THE BELOW LINK TO VIEW
http://utilities.cept.gov.in/dop/pdfbind.ashx?id=5151
*********************
REVISION
OF INTEREST RATES FOR THE SMALL SAVINGS SCHEMES FOR THE 4TH QUARTER OF THE YEAR
2020-21
*********************
REIMBURSEMENT OF COST OF OPD MEDICINES :
SPECIAL SANCTION IN VIEW OF COVID19 TILL 28TH FEBRUARY 2021 (CLICK THE BELOW LINK TO VIEW)
https://cghs.gov.in/showfile.php?lid=5951
*********************
THE DEPARTMENT OF POSTS WINS THE ‘DIGITAL INDIA GOLD AWARD
2020' IN THE CATEGORY OF ‘EXCELLENCE IN DIGITAL GOVERNANCE (CENTRAL MINISTRY
AND DEPARTMENT)'
*********************
PRESS NEWS
MINISTRY OF COMMUNICATIONS
POSTAL DEPARTMENT ISSUES NOTICE ON
UPDATING CUSTOMS DATA OF ARTICLES CONTAINING GOODS
Posted On: 31 DEC 2020 6:55PM by
PIB Delhi
Department of Posts,
Ministry of Communications, has issued a Public Notice on Updating Customs
data of Articles containing goods.
The notice states , “ As
per rule 47 of Post Office Guide Part 2 and other relevant rules, it is
mandatory that all postal articles including ordinary articles containing goods
meant for delivery to foreign destinations are affixed with correct and
complete relevant custom declaration forms. These forms include details of
sender and recipient along with descriptions of the contents of the article.”
Department of Posts
reiterated for information of customer/ public that in the absence of correct
and complete Custom Declaration forms (CN22/ CN23), such articles will not be
processed and will be returned to the sender as per departmental rules.
Information of CN forms
and other details/ guidelines are available at https://www.indiapost.gov.in/MBE/Pages/Content/MoreInfo.aspx#Custom_forms_and_Regulations
(Release ID: 1685142) Visitor Counter
Tuesday, December 29, 2020
FREQUENTLY
ASKED QUESTIONS ON COVID-19 VACCINE
FREQUENTLY ASKED QUESTIONS ON COVID-19 VACCINE FOR GENERAL PUBLIC AND
HEALTHCARE PROVIDERS/FRONTLINE WORKERS
FREQUENTLY ASKED QUESTIONS ON COVID-19 VACCINE
TARGET GROUP: GENERAL
PUBLIC
|
S.No. |
Question |
Potential response |
|
1 |
Is a COVID vaccine
scheduled soon anytime? |
Yes, vaccine trials are under different
stages of finalization. Government of India is geared to launch a vaccine for
COVID 19 soon. For more information and updates visit www.mohfw.gov.in |
|
2 |
Will COVID 19 vaccine be
given to everyone simultaneously |
Based on the potential availability of
vaccines the Government of India has selected the priority groups who will be
vaccinated on priority as they are at higher risk. The first group includes healthcare and frontline
workers. The second group to receive COVID 19 vaccine will be persons over 50
years of age and persons under 50 years with comorbid conditions. |
|
3 |
Is it mandatory to take
the vaccine? |
Vaccination for COVID-19 is voluntary.
However, it is advisable to receive the complete schedule of COVID-19 vaccine
for protecting one-self against this disease and also to limit the spread of
this disease to the close contacts including family members, friends,
relatives and co-workers. |
|
4 |
Will the vaccine be safe
as it is being tested and introduced in a short span of time? |
Vaccines will be introduced in the country
only after the regulatory bodies clear it based on its safety and efficacy. |
|
5. |
Can a person presently
having COVID-19 (confirmed or suspected) infection be vaccinated? |
Person with confirmed or suspected COVID-19
infection may increase the risk of spreading the same to others at
vaccination site. For this reason, infected individuals should defer
vaccination for 14 days after symptoms resolution. |
|
6. |
Is it necessary for a
COVID recovered person to take the vaccine? |
Yes, it is advisable to receive complete
schedule of COVID vaccine irrespective of past history of infection with
COVID-19. This will help in developing a strong immune response against the
disease. |
|
7 |
Out of the multiple
vaccines available, how is one or more vaccine chosen for administration? |
The safety and efficacy data from clinical
trials of vaccine candidates are examined by Drug regulator of our country
before granting the vaccine chosen for license for the same. Hence, all the
COVID-19 vaccines that receive license will have comparable safety and
efficacy.However, it must be ensured that the entire schedule of vaccination
is completed by only one type of vaccine as different COVID-19 vaccines are
not interchangeable. |
|
8 |
Does India have the
capacity to store the COVID vaccine at temperature of +2 to +8 degree Celsius
and transport them at |
India runs one of the largest Immunization
programme in the world, catering to the vaccination needs of more than 26
million newborns and 29 million pregnant women. The programme mechanisms are
being strengthened / geared up to effectively cater to the country’s large
and diverse population. |
|
9. |
Will the vaccine
introduced in India be as effective as the ones introduced in other countries? |
Yes. The COVID 19 vaccine introduced in
India will be as effective as any vaccine developed by other countries.
Various phases of vaccine trials are undertaken to ensure its safety and
efficacy. |
|
10. |
How will I know if I am
eligible for vaccination? |
In the initial phase, COVID 19 vaccine will
be provided to the priority group- Health Care and Front-line workers. The 50 plus age group may also begin early
based on vaccine availability. The eligible beneficiaries will be informed
through their registered mobile number regarding the Health Facility where
the vaccination will be provided and the scheduled time for the same. This
will be done to avoid any inconvenience in registration and vaccination of
beneficiaries. |
|
11. |
Can a person get the
COVID-19 vaccine without registration with Health Department? |
No, registration of beneficiary is mandatory
for vaccination for COVID 19. Only after registration the information on the
session site to visit and time will be shared with the beneficiary. |
|
12 |
What documents are
required for registration of eligible beneficiary? |
Any of the below mentioned ID with Photo may be produced at
the time of registration: • Driving License |
|
13 |
Will a Photo / ID
be required at the time of
registration? |
The Photo ID produced at the time of
registration must be produced and verified at the time of vaccination |
|
14 |
If a person is not
able to produce Photo ID at
the session site, whether
s/he be vaccinated or not? |
Photo ID is a must for both registration and
verification of beneficiary at session site to ensure that the intended
person is vaccinated |
|
15 |
How will the beneficiary receive information about due date of vaccination? |
Following online registration, beneficiary
will receive SMS on their registered mobile number on the due date, place and
time of vaccination. |
|
16. |
Will vaccinated
beneficiaries receive information on the status of their vaccination after
completion? |
Yes. On getting due dose of COVID 19
vaccine, the beneficiary will receive SMS on their registered mobile
number.After all doses of vaccine are administered, a QR code based
certificate will also be sent to the registered mobile number of the
beneficiary. |
|
17. |
If one is taking
medicines for illnesses like Cancer, Diabetes, Hypertension etc, can s/he
take the COVID- 19 vaccine? |
Yes. Persons with one or more of these
comorbid conditions are considered high risk category. They need to get COVID
-19 vaccination. |
|
18. |
Are there any preventive
measures and precautions that one needs to follow at the session site? |
We request you to rest at the vaccination
centre for atleast half an hour after taking the COVID-19 vaccine. Inform the
nearest health authorities I ANM I ASHA in
case you feel any discomfort or uneasiness subsequently.Remember to continue
following key COVID Appropriate Behaviours like wearing of mask, maintaining
hand sanitization and physical distance (or 6 feet or Do Gaj). |
|
19 |
What about
the possible side-effects from COVID-19 vaccine? |
COVID Vaccine will be introduced only when
the safety is proven. As is true for other vaccines, the common side effects
in some individuals could be mild fever, pain, etc. at the site of injection. States have been asked to start making
arrangements to deal with any Covid-19 vaccine-related side-effects as one of
the measures towards safe vaccine delivery among masses. |
|
20. |
How many doses of the
vaccine would have to be taken by me and at what interval? |
Two doses of vaccine, 28 days apart, need to
be taken by an individual to complete the vaccination schedule. |
|
21. |
When would antibodies
develop? After taking first dose, after taking second dose, or much later? |
Protective levels of antibodies are generally
developed two weeks after receiving the 2nd dose of COVID-19 vaccine. |
TARGET GROUP:
HEALTHCARE PROVIDERS/FRONTLINE WORKERS
|
Sl No. |
Question |
Potential response |
|
1. |
Why am I being chosen
for COVID 19 vaccine? |
Government of India has prioritised the most
at risk/high risk groups which will get the vaccine first. Healthcare
providers have led the battle against COVID 19 from the front. The government
wants you to be able to continue your work, without the fear of risk
associated with the virus. Therefore, healthcare and frontline workers are
among the first group of people to be vaccinated in the country. |
|
2. |
What are the groups to
be vaccinated in the first phase? |
Based on the potential availability of
vaccines the Government of India has selected the priority groups who will be
vaccinated on priority as they are at higher risk. The first group includes healthcare workers
because they are at high risk of contracting the infection and protecting
them helps to sustain essential health services. The vaccination of frontline
workers will help in reducing the societal and economic impact by reducing
COVID- 19 mortalities. The next group to receive COVID 19 vaccine will be
persons over 50 years of age and persons under 50 years with comorbid
conditions because there is high mortality in this category. The reason for including more than 50 years
of age group for vaccination is that it will be able to cover 78% of persons
having co-morbidities and thereby reduce mortality on account of COVID-19. |
|
More than 50 years of age group is divided
into two sub groups. One sub group is 60 years and above, they will be
vaccinated first. Second sub- group is between 50 to 60 years age group, they
will be vaccinated after the first sub group is covered. The vaccination may not be sequential. It
can go in parallel for all beneficiaries depending on the availability of the
vaccine. |
||
|
3. |
Will my family members
also be given the vaccine? |
Due to the limited vaccine supply in the
initial phase, it will first be provided to people who are at higher risk of
contracting COVID-19. In subsequent phases the COVID 19 vaccine will be made
available to all others in need of the same. |
|
4. |
Is this vaccine safe? |
Yes. Safety and efficacy of vaccine will be
ensured through various phases of vaccine trials and only then a vaccine will
be introduced. |
|
5. |
Does
one need to follow preventive measures such as wearing a mask, hand
sanitization, social distancing after receiving the COVID 19 vaccine? |
Even after receiving the COVID 19 vaccine,
we must continue taking all precautions like use of face cover or masks, hand
sanitization and maintain distancing (6 feet or Do Gaj). These behaviours
must be followed both at the session site and in general. |
|
6. |
Are
there any common side- effects of this vaccine? |
The COVID 19 vaccine will be safe and
effective but may have minor side effects like fever, pain, etc. at the
injection site. These effects can happen in any vaccine. |
Source: mohf
Saturday, December 26, 2020
SHRI MAHAVEER PRASAD JI BEREAVED
Shri Banwari Lal Sharma Brother of Shri Mahavir Prasad Ji, Office Staff of NFPE (HQ) New Delhi expired yesterday on 25.12.2020 at his native place in Alwar District (Rajasthan). He was suffering from Cancer.
NFPE HQ conveys heartfelt condolences to Shri Mahaveer Prasad Ji and bereaved family.
May
his soul Rest in Peace
Friday, December 25, 2020
Tuesday, December 22, 2020
TRAVELLING ALLOWANCE
RULES – PRODUCTION OF RECEIPTS/VOUCHERS FOR REIMBURSEMENT OF TRAVELLING CHARGES
FOR TRAVEL WITHIN THE CITY ADMISSIBLE UNDER DAILY ALLOWANCE ON TOUR
No. 19030/2/2020-E.IV
Government of India
Ministry of Finance
Department of Expenditure
North Block, New Delhi
Dated 22nd December, 2020
OFFICE MEMORANDUM
Subject: Travelling Allowance Rules – production of receipts/vouchers
for reimbursement of Travelling charges for travel within the city admissible
under Daily Allowance on tour- regarding.
The undersigned is directed to refer to Para 2
(E) (i) & (ill) of this Department’s OM No.
19030/1/2017-E.IV dated 13.07.2017 regarding Travelling
Allowance Rules — Implementation of 7th CPC vide which reimbursement for
Travelling Charges for travel within the city admissible under Daily Allowance
on Tour, has been prescribed. As per Para 2E(iii) of this O.M. Level 8 &
Below have been allowed reimbursement of Travelling Charges without production
of vouchers against self — certification and Level 9 & above have to
produce vouchers.
2. Several
references have been received in this Department regarding difficulties being
faced by the officials in Pay Level 9 to 11 for production of receipts/vouchers
while claiming reimbursement of Travelling Charges for travel within the city
admissible under Daily Allowance on Tour as per Para 2E(i) of Annexure to this
Department’s OM dated 13.07.2017.
3. The matter has
been considered in this Department and it has been decided that for
reimbursement of Travelling Charges admissible under Daily Allowance on tour as
mentioned in Para 2E(i) of OM dated 13.07.2017, condition of production of
receipts/vouchers for officials in Pay Level 9 to 11, is done away with subject
to furnishing of self-certification in which officials have to indicate the
period of travel, vehicle Number etc.
4. In their
application to the persons belonging to the Indian Audit & Accounts
Department, this order is issued under Article 148(5) of the Constitution and
after consultation with the Comptroller & Auditor General of India.
9. This is issued with the approval of
Secretary (Expenditure).
Hindi version is
attached.
Sd/-
(Nirmala Dev)
Director
To,
All Ministries and
Departments of the Govt. of India etc. as per standard distribution list.
Copy to : C&AG and
U.P.S.C. etc. as per standard endorsement list.
Subscribe to:
Posts (Atom)
